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Abstract
Dry eye is a multifactorial, progressive, and chronic disease of the tears and ocular surface. The disease is
multi-factorial and has intermittent symptoms. Discomfort, visual disturbance, tear film instability with potential
damage to the ocular surface, and increased tear film osmolarity are known associates.
Dry eye is a common clinical problem for eye-care providers worldwide and there is a large number of clinical
investigative techniques for the evaluation of dry eye. Despite this, however, there is no globally accepted guideline
for dry eye diagnosis and none of the available tests may hold the title of the ‘gold standard’. The majority of the
techniques involved in the diagnosis of the disease, particularly for its early stages, has a large degree of
subjectivity.
The purpose of this article is to review existing dry eye investigative techniques and to present a new objective dry
eye screening technique based on optical coherence tomography.
Keywords: Dry eye, Shrimer’s test, TBUT test, Inflammation, OCT, Epithelial thickness, Anterior-segment
Background
Dry eye disease [1] is responsible for major population
morbidity and considerable economic impact in terms of
both direct and indirect costs [2] because of the disease’s
progressive nature and the significant toll on quality of
life [3]. In addition, it may present major challenges in a
refractive surgery candidate assessment [4]. Its condition
may range from mild/episodic to severe/chronic: the dis-
order can be manifested with many symptoms including
visual disturbance (blurred and fluctuating vision),
foreign-body sensation and eye discomfort (patient-re-
ported), irritation, ocular surface inflammation, redness,
excess tearing, and photosensitivity [5–9].
Contributing factors to dry eye may be classified as
ocular, medical, pharmaceutical, iatrogenic, environmen-
tal, and contact lens wear [10].
Ocular conditions include eyelid (blepharitis) and ocu-
lar surface inflammation, and chemical burns. Medical
conditions include Sjögren’s syndrome, [11] vitamin-A
and omega-3 fatty acid deficiency, rheumatoid arthritis
and other rheumatologic diseases, as well as diabetes
and thyroid problems. Reactions to certain medications
such as antihistamines, diuretics, sleeping pills, decon-
gestants, blood-pressure medications and antidepres-
sants, postmenopausal estrogen therapy medications,
and isotretinoin-type drugs for acne treatment, may con-
tribute in their capacity to impact tear production [12].
Iatrogenic conditions include eyelid/facial surgery and
corneal refractive surgery. Specific to laser in situ kerato-
mileusis (LASIK), although pre-existing dry eye may be
subclinical, a sizable portion of LASIK patients may de-
velop reduced basal tear flow, [13] attributed to surgical
severing of the nerves by the creation of the LASIK flap,
[14, 15] and/or by the excimer laser ablation [16]. Envir-
onmental conditions include aridity, cold/windy air, and
repetitive occupational tasks that require increased con-
centration that affect blinking [17].
Review
Clinical investigative techniques for the evaluation of dry
eye
The importance of proper and timely distinction between
healthy and affected eyes is unquestionable [18–20].
There is a large number of clinical investigative tech-
niques for the evaluation of dry eye. The current options
include slit-lamp observations, tear film stability
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assessment (invasive/non-invasive tear-film breakup time
(TBUT) measurement, tear film interferometry), [21]
tear secretion assessment tests (Schirmer lacrimation
with or without anesthesia, thread methods), tear clear-
ance assessment (fluorescein clearance test, tear function
index, fluorophotometry), [22] ocular surface damage
assessment (corneal and conjunctival, rose Bengal, lissa-
mine green staining, cytology), [23] lipid layer assess-
ment (precorneal/meibomian grading), [24, 25] tear
osmolarity tests, [26–29] and patient subjective symp-
tom questionnaires [30].
However, the problem of definite dry eye assess-
ment is bedeviled by many parameters and several
aspects may make a safe diagnosis challenging par-
ticularly in the early or mild stages. Poor diagnostic
test repeatability [31] that is manifested as significant
false-positive/negative rates, [32] broad range of vari-
ability, wide range of sensitivity and specificity, and
dependence on clinical conditions [33] are some of
the reasons cited [34].
We also have to consider the multi-factorial nature of
the disease and the intermittency of the symptoms: there
is a continuum of susceptibility and possible overlay/
interference of the presented symptoms with other ocu-
lar irritations and environmental influences [35]. Sea-
sonal and diurnal variations are also factors that may
affect symptoms [36].
Another aspect is that among the prevailing investiga-
tive techniques such as Schrimer’s lacrimation and
TBUT tests, there are examiner subjectivity, [37] exter-
nal stimuli influence, [38] and accurate documentation
difficulty [39]. The same is true for investigative tech-
niques based on patient-reported symptom question-
naires [40–42]. Published evidence suggest that clinical
dry eye symptoms alone may be insufficient for proper
diagnosis of the disease [43, 44].
Adding to the challenge is the fact that despite the ex-
istence of several dry eye scoring systems, [45] there is
no globally-accepted guideline for dry eye diagnosis and
none of the available tests may hold the title of the ‘gold
standard’ [46]. With no widely accepted gold standard
against which to measure the tests, manipulation of the
diagnostic criteria used for the standard can affect the
reported sensitivity of new tests.
The other end of the problem is that there is no estab-
lished clear-cut threshold for early-stage dry eye definite
assessment. This aspect hinders the adoption of cut-off
values for any traditional metric. The problem of estab-
lishing precise cut offs between normal and dry eye pa-
tients lies less with the test and more with the
understanding that like almost all diagnostic tests, not
every individual has the same threshold for revealing
disease but rather there is a range in the population; one
that the clinician should have a clear understanding of
in regards to disease development. Notwithstanding that,
cut offs with highly useful clinical utility are available
and supplementary values e.g., inter-eye differences in
tear osmolarity, add to the specificity of the tests.
There is a critical need therefore, for a consensus of
newer/updated investigative techniques and metrics that
will better reflect the differential discrimination of the
disease [33].
In search for an objective dry eye assessment technique
A novel objective investigative technique for dry eye
screening that has been recently proposed by our team
is the objective evaluation of epithelial thickness by
anterior-segment optical coherence tomography (AS-
OCT) [47]. Specifically, overall epithelial thickness may
reflect conditions such as moderate or even subclinical
dry eye and may aid in the timely diagnosis.
Why epithelium?
It has been established that the epithelial layer thickness
and morphology may be influenced by hypoxia, [48]
contact lens wear, [49, 50] corneal ectasia, [51] corneal
cross-linking, [52] and ocular surgery such as clear-
cornea incision cataract removal, [53] corneal lamellar
surgery, [54] and corneal refractive surgery [55, 56].
Epithelial thickening may be an alarming indication
for corneal abnormality. In a previous investigation of
the three-dimensional epithelial thickness in keratoconic
eyes, [51] we identified an overall thicker epithelium that
might be a result of a reactive process; the epithelium
appears to thicken in less ‘rigid’ corneas due to being
more susceptible to mechanical variations produced by
one or a combination of factors including eye rubbing
and increased blinking mechanism [57].
Regarding dry eye, advanced stages may be reflected as
morphological epithelial damage [58]. Increased epithe-
lial thickness has been associated with dry eye in a rat
model, and has been associated with the inflammatory
process [59]. Atopic keratoconjunctivitis has been asso-
ciated with significant alterations of the basal epithelium,
and subbasal and stromal corneal nerves, related to the
changes in tear functions and corneal sensitivity [60].
Studies with scanning microscopy have identified altered
central epithelial thickness in dry eyes [61] or epithelial
thickness irregularities in cases with Sjögren’s syndrome
[62, 63]. In a confocal laser scanning microscopy study,
[64] the mean superficial and intermediate epithelial cell
densities in the central cornea in the dry eye groups
were significantly lower than in normal participants. Dry
eye corneas showed significant corneal epithelial alter-
ations, presumably due to increased desquamation of
the superficial cell layer.
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The case for OCT
In the past, the available investigating and clinical evalu-
ation modalities for the purpose of epithelial thickness
imaging have been high-frequency ultrasound (HF-
UBM), time-domain OCT, and confocal microscopy
through focusing (CMTF) [65]. None of these were fully
clinically applicable and/or had a commercially available
model for this specific use. For example, HF-UBM em-
ploys fluid coupling, which explains why we have not
identified any reports on dry eye and HF-UBM measure-
ments. CMTF requires instrument interface contact with
the cornea, and had been restricted in this application
due to the degraded precision by eye movement during
the long acquisition time. Other available techniques are
either invasive or require contact between the probe and
the ocular surface, and thus cannot provide precise in
vivo measurement of the entire epithelial thickness.
OCT has the advantage of the ease of in vivo non-
contact application and speed of optical imaging [66].
Until recently, however, its application in epithelial thick-
ness imaging involved either investigator-modified soft-
ware/hardware [67–69] or caliper software measurement
techniques [58, 70] (for example, by manually placing cur-
sors to measure epithelial thickness in each location).
The novelty offered by the Fourier-domain anterior-
segment OCT system RtVue-100 (Optovue Inc., Fremont,
CA) is that it is the first OCT system that incorporates
epithelial thickness maps (extending, currently up to 6-
mm diameter) analysis. In each meridional scan, the sys-
tem software automatically identifies the air-tear film
interface and the epithelium-Bowman layer interface. The
report then provides the pachymetry maps of both total
corneal and corneal epithelial thickness shown in Fig. 1.
This screening examination may be included in the rou-
tine screening protocol of all patients [71]. Thus, this
examination potentially presents a practical clinical tool
for qualitative (by evaluation of the three-dimensional epi-
thelial thickness mapping) and quantitative epithelium
evaluation (data for absolute average, central, and periph-
eral epithelial thickness measurements). This investigation
revealed that the measurement repeatability was of the
order of 1 μm, and the topographic thickness variability
was found to be of the order of 0.25 μm [71]. There were
some epithelial thickness differences between male and fe-
male groups (Female group average 52.58 ± 3.19 μm, Male
group average 54.10 ± 3.34 μm). Topographic thickness
variability between the two groups did not differ at the
0.05 level of significance (p = 0.173). Age also appeared to
be an influencing factor: epithelial thickness for the youn-
ger group was 52.95 ± 3.44 μm, while for the older group
was 53.64 ± 3.21 μm (not statistically significant, however).
OCT epithelial thickness mapping with this system
has recently gained clinical impetus and research interest
by other teams as well [72, 73].
A new proposition
In pursuit of an objective, repeatable, and quantitative
clinical test that may aid in the differential diagnosis of
dry eye, we introduced the concept of corneal epithelial
thickness as a possible tool in dry eye assessment, and
reported initial clinical results regarding three-
dimensional corneal epithelial thickness mapping in dry
eye corneas employing the RtVue-100 OCT system [47].
Our study suggested that there is a statistically signifi-
cant thicker corneal epithelium in mid-aged female
population diagnosed with moderate dry eye in compari-
son to an age-matched control population.
We believe that the clinical difference observed might
play a role in routine screening and treatment assess-
ment, which may precede the specific dry eye measure-
ments that may or may not be part of a standard
screening protocol. The findings reported herein may
also be very useful in the screening of refractive surgery
candidates, and even in the assessment of post-operative
iatrogenically induced dry eye [13].
In a recent study by Cui et al. [74] central epithe-
lium thickness in dry eyes, measured by the same
Fourier-domain OCT, was found to be significantly
thinner than that in normal eyes. Notably, the thinner
tendency was larger in the more severe stages. Our
team has also identified thinning and increased topo-
graphic variability of the epithelium in older age-
patients [71]. It is possible that in advanced stages in
older-age patients, the chronic insidious injury by a
deficient tear film or the destruction of stem cells at
the limbus may be likely causes for epithelial thin-
ning. In addition, we emphasize that one should not
only take into account the central epithelial thickness,
but also information deriving from the overall epithe-
lial thickness, as due to immune and angiogenic priv-
ilege, central cornea may be less sensitive to
inflammation than the limbus and conjunctiva [75].
Further cell morphology studies in epithelial thickness
associated with dry eye i.e., with confocal microscopy,
may be warranted to differentiate these noted differ-
ences, which may include epithelial hypertrophy/ hyper-
plasia, swollen cells, and/or increase in the number of
cellular layers.
The anticipated clinical ramifications of the applica-
tion are prospectively very positive since this screen-
ing indicator is based on a commercially available
instrument that can easily be integrated into daily
clinical practice and with increasing clinical screening
potential.
Our investigation
We conducted a comparative retrospective investigation
forming two groups. The ‘control’, group A (n = 70 eyes,
35 patients), consisted of ambulatory female patients
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Fig. 1 Representative thickness maps provided by the OCT system report, including total corneal, and corneal epithelium thickness maps.
Top-a is a typical example from a ‘normal-group’ patient, while bottom-b from a dry-eye patient
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with unoperated, normal eyes with no ocular pathology
other than refractive error, and no dry eye condition,
confirmed by a complete ocular clinical evaluation. The
‘dry eye‘, group B (n = 70 eyes, 35 patients), consisted of
female patients with clinically confirmed dry eye, other-
wise unoperated and with no other ocular pathology
save for possible refractive error. All patients signed an
informed consent form, releasing anonymous data evalu-
ation for scientific purposes.
Both groups consisted of female patients with dry eye
because they compose 10:1 compared to males as ob-
served in our clinical practice (unpublished data). Dry
eye was diagnosed via TBUT measurement (dry eye con-
sidered if under 5 s) and Schirmer basic lacrimation test
(dry eye considered if under 5 mm). Exclusion criteria
were anterior basement membrane and other corneal
dystrophies, and/or rheumatic diseases. No patient with
reported previous use of contact lens nor with recent
dispensing of artificial tear drops was enrolled in this
study in either group.
For each eye we measured and analyzed statistically
within the central 5 mm zone the average, superior, and
inferior epithelial thickness, as well as topographic thick-
ness variability, as reported by the standard deviation of
the seventeen (17) segments (shown in Fig. 1) local
thickness measurements. Average epithelium thickness
was computed for each case within the 5 mm zone as
the average of the seventeen segments local thickness
measurements. Examples of such maps from each group
are shown in Fig. 1.
The study suggested an overall thicker epithelium in
the group of dry eye female patients, and specifically, a
statistically different epithelial thickness between the dry
eye and control groups. The differences (average in dry
to normal eyes) ranged, for the central thickness by +6.5
μm and for the average thickness by +6.2 μm. Details
are reported in [47] and [76].
Despite the overlap in the thickness between control
and dry eye epithelial layer thickness, these differences
were statistically significant. Moreover, these differences
were larger than the repeatability measurement fluctua-
tions. In a recent evaluation [71] of a large population of
healthy eyes (373 cases), average epithelial thickness re-
peatability was at 0.8 ± 0.7 μm.
Increased epithelial thickness may also be encountered
in ectatic corneas. The differentiating factor between the
thicker ‘dry eye’ and the thicker keratoconic epithelium
lies in the topographic thickness variability. In normal
eyes, we measured an average of 1.8 ± 1.1 μm [71]. In
the dry eye study, the topographic thickness variability
was 2.5 ± 1.5 μm, slightly larger than in the ‘healthy eye’
population, while in the keratoconic study thickness
variability was found to be significantly larger (up to
10.3 μm), thus enabling differentiation.
In this study, the specific imaging with the RtVue sys-
tem might also influence dry eye epithelial measurements
by the AS-OCT device. In a previous OCT study of epi-
thelial thickness by Francoz et al. [58] with a different in-
strumentation, difference between central epithelial
thickness between middle-aged normal (48.8 ± 3.0 μm)
and dry eye population (49.0 ± 4.1 μm) was much smaller.
This can be attributed to investigative differences: in the
current study, average epithelial thickness was accurately
reported on the select meridian scans and interpolated on
the space between while the study by Francoz et al. imple-
mented manual position on select scanned meridians to
measure epithelial thickness. The different geographical
locale might also be a factor.
Conclusions
Among the newly emerging dry eye testing options, tear
film osmolarity may be considered an objective tech-
nique. The test employs a disposable test chip (TearLab
Corp., San Diego, CA) that collects a small (50 nL) tear
sample from the lower meniscus [77]. Analysis is based
on electrical impedance (milliosmoles per liter) of the
tear sample [28].
Newly emerging techniques that may be considered
are thermography, [78] a technique incorporated in a
clinical autorefractor/keratometer (RC 5000; Tomey
Corporation, Nagoya, Japan), as well as the noninvasive
tear breakup time recorded and digital measurement
with an optional feature of a corneal Placido-ring topog-
rapher (Keratograph 5M; Oculus Optikgeräte GmbH,
Wetzlar, Germany) [79].
Sensory testing could also be useful diagnostically, not-
withstanding issues relating to altered corneal epithelial
barrier function [80, 81].
We introduced and presented a novel dry eye screen-
ing technique based on a clinical OCT device. The
screening is part of our established protocol not only for
dry eye, but also for general evaluation of the cornea;
thus the potential for dry eye alert comes as a collateral
benefit. We emphasize that the clinical diagnostic cap-
acity of the increased overall epithelial thickness that we
introduced has importance for early-stage, subclinical
dry eye, and not severe dry eye, for which many other
techniques may offer a more concrete diagnosis.
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